Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.

Chronic cough has not traditionally been listed as a common adverse effect of GLP-1s. According to Jeff Stanley, MD, ...

In this episode of Disruption Interruption, Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms to discuss revolutionizing respiratory diagnostics. Circo explains how Hyfe uses AI to turn ...

Statistically-significant reduction in the relative change from baseline in 24-hour objective cough frequency observed across all dose groups of nalbuphine ER at Week 6 with statistically-significant ...

Nalbuphine extended release (ER) significantly reduces cough frequency and severity in patients with idiopathic pulmonary fibrosis (IPF), especially at higher doses, compared with placebo. The trial ...

20%-46% of patients with chronic cough, defined as a cough lasting for more than 8 weeks, have RCC, a persistent cough despite thorough investigation and treatment. RCC and its physical and mental ...

Chronic cough is undergoing a pivotal shift—from being viewed merely as a symptom to being recognized as a distinct disease entity. From December 4 to 6, 2025, the 5th International Cough Conference ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

If you’re not careful, combating dry winter air could put a whole new problem on your plate this winter. When temperatures drop and cold and flu season kicks in, many turn to humidifiers to soothe ...